Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP223541.RAOnOMIBxwYb3-ezg891MHjMAjfDsFJ_mdI6BF366qaDw130_assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223541.RAOnOMIBxwYb3-ezg891MHjMAjfDsFJ_mdI6BF366qaDw130_provenance.
• assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP660163.RAjTanEJnArsqpOj-NnfN3IiBztdZwqGISG8j-qzPbCEc130_assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660163.RAjTanEJnArsqpOj-NnfN3IiBztdZwqGISG8j-qzPbCEc130_provenance.
• NP450942.RAwNLEgnzFXN7mVGnqnoRWsW5i7-8hxQWj6CNPvc5mEXY130_assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450942.RAwNLEgnzFXN7mVGnqnoRWsW5i7-8hxQWj6CNPvc5mEXY130_provenance.
• NP475546.RAZwcKHbchqxl6Wf2YJUSQCGT-9_lL6ydbcHb0Y4KoOVo130_assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475546.RAZwcKHbchqxl6Wf2YJUSQCGT-9_lL6ydbcHb0Y4KoOVo130_provenance.
• NP891828.RA4WD16vNdy86TOuhsFI5qwJiBFyIDQ4Ho1yupV6ezOD0130_assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891828.RA4WD16vNdy86TOuhsFI5qwJiBFyIDQ4Ho1yupV6ezOD0130_provenance.
• assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP420012.RAdAtPSL_-EltiWULhdrzLaFP3fle__iA4z-nd8VnLX9Y130_assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420012.RAdAtPSL_-EltiWULhdrzLaFP3fle__iA4z-nd8VnLX9Y130_provenance.
• NP252907.RAigbrUiwsYBvgBg3TB3-XMQmDNgHJAE2eCZwr4wpVMzo130_assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252907.RAigbrUiwsYBvgBg3TB3-XMQmDNgHJAE2eCZwr4wpVMzo130_provenance.
• NP420013.RAv8TxOcnRN9oIUg_2QHQIF-X8Ksaf67HM1Wp7eBdv9W8130_assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420013.RAv8TxOcnRN9oIUg_2QHQIF-X8Ksaf67HM1Wp7eBdv9W8130_provenance.
• NP420014.RAO9P0lhnq5as1VnbA2Qj47SeG6F9lGFuhnICW324ATic130_assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420014.RAO9P0lhnq5as1VnbA2Qj47SeG6F9lGFuhnICW324ATic130_provenance.
• NP420015.RA432tO8FR0nMavYuAdcrXWQ9Al_QSmdxAs47S-YxVRe0130_assertion description "[An incidence of approximately 1 in 107,000 live births was obtained for MPS IH (Hurler phenotype); 1 in 320,000 live births (1 in 165,000 male live births) for MPS II (Hunter Syndrome); 1 in 58,000 for MPS III (Sanfilippo Syndrome); 1 in 640,000 for MPS IVA (Morquio Syndrome type A), and 1 in 320,000 for MPS VI (Maroteaux-Lamy Syndrome).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420015.RA432tO8FR0nMavYuAdcrXWQ9Al_QSmdxAs47S-YxVRe0130_provenance.